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Mutations in Frizzled 6 Cause Isolated
Autosomal-Recessive Nail Dysplasia
Anne-Sophie Fro¨jmark,1 Jens Schuster,1,6 Maria Sobol,1,2,6 Miriam Entesarian,1,5,6
Michaela B.C. Kilander,3 Dana Gabrikova,1,7 Sadia Nawaz,4 Shahid M. Baig,4 Gunnar Schulte,3
Joakim Klar,1 and Niklas Dahl1,*
Inherited and isolated nail malformations are rare and heterogeneous conditions.We identified two consanguineous pedigrees in which
some family members were affected by isolated nail dysplasia that suggested an autosomal-recessive inheritance pattern and was char-
acterized by claw-shaped nails, onychauxis, and onycholysis. Genome-wide SNP array analysis of affected individuals from both families
showed an overlapping and homozygous region of 800 kb on the long arm of chromosome 8. The candidate region spans eight genes,
and DNA sequence analysis revealed homozygous nonsense and missense mutations in FZD6, the gene encoding Frizzled 6. FZD6
belongs to a family of highly conserved membrane-bound WNT receptors involved in developmental processes and differentiation
through several signaling pathways. We expressed the FZD6 missense mutation and observed a quantitative shift in subcellular distribu-
tion from the plasmamembrane to the lysosomes, where the receptor is inaccessible for signaling and presumably degraded. Analysis of
human fibroblasts homozygous for the nonsensemutation showed an aberrant response to bothWNT-3A andWNT-5A stimulation; this
response was consistent with an effect on both canonical and noncanonical WNT-FZD signaling. A detailed analysis of the Fzd6
/mice,
previously shown to have an altered hair pattern, showed malformed claws predominantly of the hind limbs. Furthermore, a transient
Fdz6mRNA expression was observed in the epidermis of the digital tips at embryonic day 16.5 during early claw morphogenesis. Thus,
our combined results show that FZD6 mutations can result in severe defects in nail and claw formation through reduced or abolished
membranous FZD6 levels and several nonfunctional WNT-FZD pathways.Congenital nail abnormalities are most often part of ecto-
dermal syndromes involving several epidermal append-
ages, whereas isolated and inherited nail dysplasias are
very rare.1 Nail development is initiated at embryonic
week 9 by mesenchymal condensation in the dorsal
part of the distal digital tip. This is followed by the forma-
tion of a transverse nail fold while the underlying matrix
primordium expands. The matrix induces the nail bed
and, subsequently, the formation of the nail plate.2 The
formation of nails is initiated in the upper limb and
then proceeds to the hind limb, and the morphogenesis
is similar in primates and rodents. The molecular mecha-
nisms underlying these processes are poorly understood,
but recent studies have shown that WNT-FZD signaling
is important for the formation of ectodermal appendages,
including nails.3–6 In humans, mutations in the WNT-
signaling regulator PORCN (MIM 300651) are associated
with focal dermal hypoplasia (FDH) (MIM 305600),7
and mutations in the FZD agonists RSPO4 (MIM
610573) and RSPO1 (MIM 609595) are identified in
both isolated anonychia (MIM 206800)8 and palmoplan-
tar hyperkeratosis with sex reversal,9 respectively. Further-
more, WNT10A (MIM 6062689) mutations are associated
with odontoonychodermal dysplasia (OODD) (MIM
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LMX1B (MIM 602575) and MSX1 (MIM 142983),
involved in patterning and nail bed formation, cause
nail-patella (MIM 161200) and Witkop syndrome (MIM
189500), respectively.3,13,14
To gain insight into molecular mechanisms regulating
nail development, we investigated two consanguineous
Pakistani families (F1 and F2) affected by autosomal-reces-
sive isolated nail dysplasia (Figure 1A). Family F1 included
four affected individuals, and family F2 included seven
affected individuals. The affected individuals from family
F1 presented with a more severe nail dysplasia compared
to affected individuals from family F2 (Figures 1B and
1C). All affected individuals showed a variable degree of
onychauxis (thick nails), hyponychia, and onycholysis of
fingernails and toenails. Fingernails had a claw-like appear-
ance. No other disorders or anomalies of ectodermal tissues
(i.e., hair, teeth, sweat glands, or skin) were noted and indi-
viduals with dysplastic nails had normal hearing, normal
psychomotor development and reported normal sweating
as well as normal hair growth. Four affected individuals
from each family were available for clinical examinations.
Available parents to individuals with nail dysplasia pre-
sented with normal nail morphology. Informed consent
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Figure 1. Pedigrees and Phenotypes of Families Affected by Nail Dysplasia
(A) Both families are consanguineous Pakistani pedigrees, and individuals who were examined and sampled for genetic analysis are indi-
cated with numbers. Affected individuals are shown as filled symbols. Marker haplotypes on chromosome 8 spanning FZD6 locus are
shown below the symbols and were generated as described.16,17
(B) Hands and feet of individual V:1 in family F1 showing onychauxis, hyponychia, and onycholysis of both finger- and toenails. Finger-
nails are claw-shaped.
(C) Hands and feet of individual III:5 in family F2. Onychauxis and onycholysis of both fingernails and toenails are less severe in indi-
vidual III:5 than in individuals from family F1.this study, and the protocol was approved by the local
ethical board at NIBGE, Faisalabad, Pakistan.
Blood samples were collected for DNA extraction from22
available members of families F1 and F2, and we initially
genotyped DNA samples from the four affected family
members in family F1 by using the GeneChip Human
Mapping 250K SNP Array. Autozygosity mapping15 re-
vealed one large homozygous region spanning 17 Mb onThe Amethe long arm of chromosome 8 (1570 SNPs). Within this
region, affected individuals of family F2 were homozygous
over 800kb (66 SNPs) (Figure S1A, available online).Weper-
formed genetic linkage analysis by using polymorphic mi-
crosatellite markers16,17 on the long arm of chromosome
8 and obtained a maximum cumulative two-point LOD
score of 3.87 (Q¼ 0). The analysis confirmedhomozygosity
for the region in affected family members, and each familyrican Journal of Human Genetics 88, 852–860, June 10, 2011 853
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Figure 2. FZD6Mutations Associated with Autosomal-Recessive
Nail Dysplasia in Families F1 and F2
(A) The seven transmembrane FZD6 proteins showing positions of
the two predicted mutations p.Arg511C and p.Glu584X in the
intracellular domain (top). Boxes illustrate sequence chromato-
grams flanking the mutations (indicated with asterisks) from
controls, carriers, and affected individuals in F1 (right box) and
F2 (left box). The corresponding amino acid sequences are shown
for WT FZD6 (above boxes) and mutated FZD6 (below boxes). The
missense mutation is located 7 amino acids toward C-terminal of
the conserved PDZ-binding motif (KTxxxW). Bidirectional
sequence analysis of FZD6 included the seven exons, 50 and 30
UTRs, as well as the exon-intron boundaries on genomic DNA
from individuals in families F1 and F2. The two identified muta-
tions were not observed in 94 Pakistani and 110 Swedish control
individuals. Primer sequences are available upon request.
(B) Multiple species alignment of orthologous FZD6 sequences
from seven vertebrate species. The diagram shows residues
487–533 in human FZD6 (top) spanning the missense mutation
p.Arg511C (gray area) and the corresponding amino acid sequence
of orthologs. The following abbreviations are used: H.s., Homo
sapiens; P.t., Pan troglodytes; C.f., Canis lupus familiaris, B.t., Bos
taurus; M.m.,Musmusculus; R.n., Rattus norvegicus; D.r.,Danio rerio.
The PDZ-binding motif is boxed.had a distinct haplotype. The 800 kb region spans eight
genes, including FZD6 (accession number NM_003506).
We considered FZD6 a good candidate on the basis of
previous findings showing involvement of WNT-FZD
signaling in inherited anonychia as well as the role of
FZD6 in hair patterning inmice.
8,18 Sequencing of all seven
exons of FZD6 revealedhomozygosity for anonsensemuta-
tion (c.1750G>T [p.Glu584X]; NM_003506.3) in the four
affected members of family F1. In family F2 we identified
a missense mutation (c.1531C>T [p.Arg511Cys];
NM_003506.3) homozygous in the four available and
affected members (Figures 2A and 2B). The potential func-
tional importance of the missense mutation is supported
by the fact that the arginine residue is conserved in several
species, including dogs, cattle andmice (Figure 2C). In each
family, available parents of affected individuals were
heterozygous for the respective mutation and unaffected
siblings were either heterozygous for the mutation or
homozygous for the wild-type (WT) sequence. The muta-
tions were not present in chromosomes from 94 healthy
unrelated Pakistani subjects or in chromosomes from 110
Swedish blood donors.
FZD6 has previously shown to be important for the
morphogenesis of hair follicles in both Drosophila and
mice.18 Fzd6/ mice present with abnormal macroscopic
hair whorls, and Fzd3/; Fzd6/ double-mutant mice
have a disturbed pattern of inner-ear sensory hair cells
specifying a role for FZD6 in planar-cell polarity.
18,19 We re-
investigated the mouse model and found that about 50%
of male, but not female, Fzd6/ mice displayed abnormal
claw morphology or absent claws when compared to WT
mice (Figure 3A). At the age of 2 to 3months, the claws dis-
appeared or became rudimentary on the hind limbs. To
further link expression of Fzd6 to early nail development,
we investigated Fzd6 expression in mouse embryos at
embryonic day (E) 14.5, 15.5, 16.5, and 17.5 at the time
of early nail morphogenesis. Besides a general Fzd6
mRNAexpression inmurine skin,18we observed a transient
Fzd6 mRNA expression at the tip of the digits around
E16.5, (Figure 3B) supporting a role for FZD6 in nail devel-
opment. Microscopy revealed that the transient Fzd6
mRNA expression is mainly confined to the epidermis of
the digital tips in a region corresponding to the developing
nail bed and the ventral part of the digit (Figure 3C).
To determine the functional effects of the mutations, we
obtained primary fibroblasts from one individual homozy-
gous for the FZD6 nonsense mutation. The mutant fibro-
blasts expressed 13% of FZD6 mRNA levels in primary
control fibroblasts supporting nonsense-mediated mRNA
decay (Figure S1B). We were unable to obtain primary
fibroblasts homozygous for the c.1531C>Tmissensemuta-
tion.We next designed and expressed theWTas well as the
two mutant variants of FZD6 (WT; [FZD6(wt)], p.Glu584X
[FZD6(nonsense)] and p.Arg511Cys [FZD6(missense)])
fused to green fluorescent protein (GFP) in HEK293T cells.
Similar GFP levels were observed in cells expressing the
FZD6(wt) or FZD6(missense) variants, suggesting that the854 The American Journal of Human Genetics 88, 852–860, June 10,missense mutation has no or little effect on total FZD6
levels. No expression was detected from FZD6(nonsense)-
GFP (data not shown).
FZD6 belongs to the heptahelical class of FZD receptors
with an internal PDZ-interacting motif necessary for the
recruitment of the phosphoproteins Dishevelled (DVL)
1–3 (MIM 601365; 602151; 601368) and other signaling
factors as well as for trafficking of the receptor.20,21 Both
FZD6 mutations result in alterations of the intracellular2011
Figure 3. Hind-Limb Examination of the Fzd6/ Male Mice
(A) Hind paws (left panel) and single digits (middle and right panel) of adult WT mice (upper panel) and adult Fzd6/ mice (lower
panel). Fzd6/ mice display claw defects illustrated by absent or rudimentary claws (indicated by arrows). The boundaries of claw
and claw rudiments, respectively, are marked (rightmost panel).
(B) The X-Gal histochemical staining of embryonic hind limbs at E14.5, 15.5, 16.5, and 17.5 in mice heterozygous for Fzd6-nlacZ
(Fzd6þ/). Transient X-Gal expression (blue) is shown at the digital tip (indicated by arrow) at E16.5 during nail morphogenesis. The
X-Gal staining was performed in standard X-Gal staining solution as described.18
(C) Immunohistochemical staining of sectioned mice hind limbs from (B) showing X-Gal expression (brown) confined mainly to the
epidermis (indicated by red arrow) around the digital tip and with a few expressed foci in the dermis. Sections are stained with
a-X-Gal antibody (Abcam) and counterstained with hematoxylin (blue). The green asterisk denotes the digital tip and red asterisk
denotes the dorsal part. The X-gal stained hind legs were paraffin embedded, sectioned, and deparaffinized according to standard proce-
dures. Slides were scanned with the Mirax MIDI scanner (Zeiss) and analyzed with the MIRAX viewer 1.11 software.tail, and we hypothesized that FZD6 with the missense
mutation might show (1) an abnormal turnover rate (2)
an improper integration into the cell membrane, and/or
(3) reduced capability for DVL recruitment. To further
clarify any effects of the FZD6 missense variant, we
analyzed the subcellular localization of FZD6(wt)-GFP
and the FZD6(missense)-GFP by confocal imaging. Expres-
sion of the two FZD6-GFP variants in HEK293T cells re-
vealed a clear difference in subcellular distribution. The
FZD6(wt)-GFP was localized predominantly in the plasma
membrane, and a few cells showed intracellular vesicles,
whereas the FZD6(missense)-GFP showed the opposite
pattern, that is the majority of cells had FZD6(missense)-
GFP confined to intracellular vesicles (Figure 4A). In order
to quantify the observed difference, we counted cells withThe Ameplasma membrane, plasma membrane/vesicular, or pre-
dominantly vesicular patterns. Quantification revealed
that 71% of FZD6(wt)-GFP-expressing cells had a membra-
nous pattern, whereas only 14% of the FZD6(missense)-
GFP transfected cells expressed the receptor in the
membrane (Figure 4B). Conversely, 14% of the cells trans-
fected with the FZD6(wt)-GFP showed a predominantly
vesicular distribution; whereas 63% of cells expressing
the mutant receptor showed a vesicular distribution. This
suggested a quantitative defect of the FZD6 missense
variant because of defects in intracellular transportation,
impaired integration into the plasma membrane, acceler-
ated internalization, and/or an increased degradation.
The high proportion of cells expressing FZD6(missense)-
GFP localized to intracellular vesicles made us hypothesizerican Journal of Human Genetics 88, 852–860, June 10, 2011 855
Figure 4. FZD6-GFP Missense Localizes Predominantly to Intracellular Vesicles of Lysosomal Character
(A) Overexpression of FZD6(wt)-GFP and FZD6(missense)-GFP in HEK293 cells results in plasmamembrane, plasmamembrane/vesicular,
and vesicular receptor localization as assessed by confocal imaging.
(B) Quantification of cell categories according to receptor localization shows that FZD6(wt)-GFP is predominantly localized to the plasma
membrane, whereas FZD6(missense)-GFP is localized to intracellular vesicles. Quantification was performed on 200 cells per transfection
in three independent experiments. The mean values 5 standard deviation (SD) were 70.7 5 2.8 (FZD6[wt]membr); 14.3 5 2.4 (FZD6
[missense]membr), 15.55 1.3 (FZD6[wt]membr to vesic), 22.55 2.6 (FZD6[missense]membr to vesic), 13.85 1.5 (FZD6[wt]vesic),and
63.2 5 1.4 (FZD6[missense]vesic). Error bars denote5 SD.
(C) Colocalization of FZD6(wt)-GFP and FZD6(missense)-GFP transiently expressed in HEK293 cells with organelle markers (clathrin:
clathrin-coated pits and early endosomes; transferrin: plasmamembrane and recycling endosomes; caveolin-1: caveolae; RAB5: early en-
dosomes; TGN46: trans-Golgi network; lysotracker: lysosomes). Arrows indicate apparent colocalization. The scale bar indicates 10 mm.
The human FZD6 construct was generated from the cDNA clone (IRAKp961D01133Q, imaGenes) and introduced into the vectors
pAcGFP-N1 (FZD6). The FZD6 missense mutation (c.1531C>T) was introduced by in vitro mutagenesis (QuickChange II Site-Directed
Mutagenesis Kit, Stratagene) into the pFZD6(wt)-GFP clone according to manufacturer’s instructions. Transfection of HEK293T cells
was performed with the calcium phosphate method and analyzed for GFP and expression by fluorescence microscopy on an LSM710
confocal microscope (Zeiss) 2 days after transfection. The following antibodies and markers were used for intracellular organelles: rabbit
anti-clathrin (Abcam, ab14408), rabbit anti-caveolin-1 (Abcam, ab2910), rabbit anti-RAB5 (Abcam, ab13252), mouse anti-TGN46
(Abcam, ab2809), lysotracker DN-99, and Alexa555-coupled transferrin (Invitrogen).that the vesicles could belong to either the endosomal, cav-
eosomal, or lysosomal pathway. In order to clarify the
nature of the FZD6-GFP-positive intracellular vesicles, we
performed colocalization experiments by using transferrin
and antibodies against clathrin, caveolin-1, RAB5, the
trans-Golgi network marker TGN46, and a lysosomal
marker, lysotracker, in combination with the FZD6(wt)-
GFP and FZD6(missense)-GFP, respectively. We could not
detect any overlap with clathrin-, caveolin-1-, or RAB5-
labeling endosomal compartments (Figure 4C). Further-856 The American Journal of Human Genetics 88, 852–860, June 10,more, the trans-Golgi network marker TGN46 did not co-
localize with GFP, indicating that the vesicular structures
do not represent compartments in the excocytotic
pathway. A partial colocalization was observed for GFP
and transferrin, which is bound to the plasma membrane
and some endosomal compartments. In contrast, we
observed a clear colocalization for both FZD6(wt)-GFP
and FZD6(missense)-GFP and lysotracker. This shows
that the intracellular vesicles, observed predominantly
in FZD6(missense)-GFP-expressing cells, are lysosomes.2011
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Figure 5. FZD6-GFP-Mediated Recruitment of
DVL1-FLAG
Overexpression of DVL1-FLAG in the absence of
FZD6 in HEK293 results in punctuate DVL1-
FLAG localization as shown in confocal micro-
photographs (upper panel). Coexpression of
DVL1-FLAG with either FZD6(wt)-GFP or
FZD6(missense)-GFP induces a redistribution
and a recruitment of DVL1-FLAG to the plasma
membrane (mid- and lower right). DVL1-FLAG
is N-terminally tagged (from Madelon Maurice,
Utrecht, The Netherlands). The scale bar indicates
10 mm.Thus, our observations indicate a quantitative shift of
FZD6(missense)-GFP from the plasma membrane to lyso-
somes consistent with increased lysosomal degradation.22
FZDs contain a highly conserved KTxxxW sequence in
the C terminus, just upstream of the mutated residue in
missense FZD6.
21 This domain is crucial for intracellular
recruitment and interaction with Dishevelled (DVL)
proteins, and we asked whether the recruitment of DVL
is affected by the missense mutation. FZD6(wt)-GFP and
FZD6(missense)-GFP were coexpressed with DVL1-FLAG
in HEK293 cells. In the absence of FZD6 expression,
DVL1-FLAG-positive cells showed characteristic aggregates
in the cytosol in addition to a smaller percentage of cells
with even distribution of DVL1-FLAG (Figure 5).23 Coex-
pression with FZD6(wt)-GFP induced a radical membrane
recruitment of DVL1-FLAG. Interestingly, the membrane
recruitment was also observed in the presence of FZD6(mis-
sense)-GFP, arguing that the mutated receptor is capable to
interact with DVL. This is supported by immunoprecipita-
tion showing that myc-FZD6(missense) binds to DVL2-3
(Figure S2). Moreover, intracellular FZD6(missense)-GFP
within the lysosomal vesicles did not attract DVL1-FLAG
(Figure 5), supporting the notion that FZD6 internalized
into lysosomes is inactivated. In addition, employing indi-
rect immunocytochemistry with an FLAG antibody and
a Cy3-conjugated secondary antibody, we investigated
the Fo¨rster resonance energy transfer (FRET) between
FZD6-GFP and DVL1-FLAG in fixed cells after photoaccep-
tor bleaching. FRET between FZD6(missense)-GFP and
DVL1-FLAG was reduced in comparison to FZD6(wt)-GFPThe American Journal of Hcoexpressed with DVL1-FLAG (Figure S3).
The combined results indicate that the
missense mutation leads to increased inter-
nalization of the receptor and subsequent
lysosomal degradation and thus a net
reduction of FZD6 receptors in the plasma
membrane.
WNT-FZD signaling constitutes a network
of autocrine and paracrine pathways regu-
lated via several feedback loops.21,24,25 The
best known signaling pathway downstream
of FZD is the WNT-b-catenin pathway
leading to the stabilization of b-cateninand TCF/LEF-dependent transcription.26 However, it has
been shown that FZD6 has the ability to interact with
both WNT-3A (MIM 606359) and WNT-5A (MIM
164975), previously shown to recruit b-catenin-dependent
as well as b-catenin-independent pathways, respectively.27
To further investigate the effect of mutated FZD6 on down-
stream signaling, we stimulated primary WT fibroblasts
and patient fibroblasts homozygous for the FZD6
nonsense mutation with either WNT-3A or WNT-5A.
WNT-3A stimulation resulted in an upregulation of b-cate-
nin levels in control fibroblasts but not in patient
fibroblasts (Figures 6A). This supports that FZD6 mediates
b-catenin-dependent signaling and that FZD6-null mutant
cells have lost their capability to respond to WNT-3A stim-
ulation. Next, we analyzed levels of the WNT-signaling
antagonist DKK1 in control and FZD6-mutated fibroblasts
stimulated with WNT-3A or WNT-5A. After WNT-5A acti-
vation we observed upregulated levels of DKK1 mRNA in
control fibroblasts but not in FZD6-null fibroblasts
(Figure 6B). This suggests a perturbed response also to
b-catenin-independent WNT-5A stimulation in the
absence of FZD6. DKK1 and several other WNT-signaling
inhibitors were recently shown to be induced by the tran-
scription factor MSX1.28 In agreement with the results
from DKK1 mRNA analysis, we observed increased MSX1
mRNA levels in WNT-5A-stimulated control fibroblasts
but not in patient fibroblasts (Figure 6C). In combination,
these results suggest that patient fibroblasts homozygous
for the FZD6 nonsense mutation fail to respond properly
to both WNT-3A and WNT-5A activation.uman Genetics 88, 852–860, June 10, 2011 857
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Figure 6. Effect of WNT-3A and WNT-5A
Stimulation On Primary Fibroblast
Cultures from an Affected Individual (V:1
form Family F1) and a Healthy Control
(A) b-catenin levels in control fibroblasts
and in fibroblasts homozygous for the
nonsense mutation p.Glu584X without
stimulation () and after WNT-3A or
WNT-5A stimulation (þ). The graphs repre-
sent the relative amounts of b-catenin to
b-actin as determinedby immunoblot anal-
ysis (bottom). b-catenin accumulates upon
WNT-3A stimulation in control cells but
not in FZD6-null mutant cells (*p < 0.05).
(B) Effect of WNT-5A stimulation on DKK1
expression. Quantitative RT/PCR analysis
from total RNA isolated from control and
mutated fibroblasts stimulated as in (A)
shows that DKK1 is upregulated in control
cells upon stimulation with WNT-5A but
not WNT-3A (*p < 0.05). Mutated fibro-
blasts do not show increased DKK1 tran-
script levels in response to WNT-5A.
(C) Effect of WNT-5A stimulation onMSX1
expression analyzed as in (B).MSX1 is upre-
gulated in control fibroblasts but not in
patient derived cells (*p < 0.05). Error bars
(in A–C) denote means5 SD.
Fibroblasts were cultured in eitherWNT-3A- orWNT-5A-conditioned RPMImedium, respectively, at 90% confluence and harvested after
24 hr and 48 hr, respectively. Levels ofDKK1 andMSX1 transcripts were analyzedwith the PlatinumSYBRGreen qPCR SuperMix-UDGkit
(Invitrogen) followingmanufacturers recommendations. For analysis of b-catenin expression, cells were lyzed in RIPA buffer (50mMTris/
Cl [pH 7.5], 150 mM NaCl, 1% Triton X-100, 1% Sodium deoxycholate, and 0.1% sodium dodecyl sulfate [SDS]). Protein samples were
separated on a 10% SDS-PAGE (NuPage, Invitrogen) and transferred to PVDF membranes (iBLOT transfer system, Invitrogen). Proteins
were detected with primary a-b-catenin (Santa Cruz Biotechnology) and a-b-actin antibodies (Abcam), respectively. Proteins were visual-
ized and quantified with the Odyssey infrared imaging system as previously described.36 Data obtained from independent tissue cultures
were pooled and analyzed with student’s two-tailed t test.During normal nail formation, the nail plate must be
properly attached to the nail bed. This process is presum-
ably dependent on tight interaction and signaling between
mesenchymal (matrix) cells forming the nail plate and the
epidermal (nail bed) cells. Affected individuals in the F1
and F2 families have a retained regenerative capacity of
the nail plate; this capacity suggests that the nail matrix is
intact. The primary defect associated with FZD6 mutations
seems to be related to perturbed formation and attachment
of the nail plate shown as onycholysis. This is also consis-
tent with the observations in the Fzd6/ mice with claws
that are easily lost with age and mechanical stress. The
reason for the restriction of the claw phenotype to male
mice is unclear, but one explanation is a more aggressive
behavior. However, it cannot be excluded that altered
WNT signaling caused by disrupted Fzd6 has a gender-
restricted effect as shown for human RSPO1mutations.9
WNT-FZD signaling is indispensable for numerous
developmental processes such as tissue morphogenesis,
differentiation, and regeneration in all animals.26 It has
become evident that many WNT-FZD interactions and
their downstream pathways are integrated in extensive
cross-talks with shared components.21,29,30 Furthermore,
FZDs have the ability to elicit different cellular responses
in different environments.31 Previous studies have shown
that FZD6 can act as a negative regulator of b-catenin
signaling32 as well as a mediator of the planar cell polarity858 The American Journal of Human Genetics 88, 852–860, June 10,(PCP) pathway.18 We show here that FZD6-null mutant
cells fail to respond to bothWNT-3A andWNT-5A stimula-
tion in vitro when compared to control cells. Hence, FZD6
can elicit both b-catenin-dependent and -independent
signaling presumably determined by the local dosage of
ligands, other FZDs, and coreceptors, as suggested from
other studies.33–35 Furthermore, subcellular studies show
that FZD6 containing the missense mutation is localized
predominantly in lysosomes when compared to the WT
FZD6. Thus, the FZD6 missense variant is presumably
subject to increased internalization and subsequent
degradation and a reduced capability to interpret WNT
stimulation. In conclusion, our combined results show
that isolated nail dysplasia can be caused by dysfunctional
FZD6 or loss of FZD6 with a subsequent misregulation of
several FZD6-mediated pathways required for proper
formation and regeneration of nails throughout life.Supplemental Data
Supplemental Data include three figures and can be found with
this article online at http://www.cell.com/AJHG/.Acknowledgments
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